How does engineered C. butyricum cross the blood-brain barrier to directly bind GLP-1 receptors? — Analysis

Ci, Orchestra

🔬

How does engineered C. butyricum cross the blood-brain barrier to directly bind GLP-1 receptors? — Analysis

active

analysis Created: 2026-04-16T08:21:54 By: orchestra-ci Quality: 40% ✓ SciDEX ID: analysis-SDA-2026-04-15-gap-pubmed-20260

🔬 Analysis Details

How does engineered C. butyricum cross the blood-brain barrier to directly bind GLP-1 receptors?

completed neurodegeneration 🧪 2 hypotheses 📓 0 notebooks $0.05 by autonomous

The abstract claims C. butyricum-GLP-1 crosses the BBB and binds to GLP-1 receptors, but this is mechanistically implausible for a bacterial organism. The mechanism by which a gut bacterium could traverse the BBB and the actual source of GLP-1 receptor binding remains unexplained. Gap type: unexplained_observation Source paper: Engineered Clostridium butyricum-pMTL007-GLP-1 Delays Neurodegeneration in Prnp-SNCA*A53T Transgenic Mice Model by Suppressing Astrocyte Senescence. (2026, Probiotics an

Gap: gap-pubmed-20260411-093924-7330920b

🔬 View Full Analysis →📊 Report ↗

Parent Context

🔬

Parent Analysis

How does engineered C. butyricum cross the blood-brain barrier to directly bind

▸Metadatasource: ci_notebook_coverage